Health status decline in α-1 antitrypsin deficiency: a feasible outcome for disease modifying therapies?

Health status decline in α-1 antitrypsin deficiency: a feasible outcome for disease modifying therapies?

Abstract Background Trials of disease modifying therapies in Chronic Obstructive Pulmonary Disease (COPD) provide challenges for detecting physiological and patient centred outcomes. The purpose of the current study was to monitor decline in health status in Alpha-1 antitrypsin deficiency (AATD) and...

Full description

Bibliographic Details
Main Authors: Robert A. Stockley, Ross G. Edgar, Sian Starkey, Alice M. Turner
Format: Article
Language:English
Published: BMC 2018-07-01
Series:Respiratory Research
Subjects:
Alpha-1 antitrypsin deficiency
Health related quality of life
Disease progression
Online Access:http://link.springer.com/article/10.1186/s12931-018-0844-6

Similar Items

Similar Items